Insider Transactions in Q2 2021 at 89bio, Inc. (ETNB)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 16
2021
|
Ram Waisbourd Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$133,000
$19.67 P/Share
|
Jun 16
2021
|
Ram Waisbourd Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$7,000
$1.93 P/Share
|
Jun 02
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
22,138
+0.44%
|
$398,484
$18.77 P/Share
|
May 28
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
123,505
+2.44%
|
$2,223,090
$18.77 P/Share
|
May 27
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
35,535
+0.73%
|
$639,630
$18.76 P/Share
|
May 26
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
48,377
+1.0%
|
$870,786
$18.03 P/Share
|
May 17
2021
|
Ram Waisbourd Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$147,000
$21.61 P/Share
|
May 17
2021
|
Ram Waisbourd Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$7,000
$1.93 P/Share
|
Apr 21
2021
|
Gregory Grunberg Director |
SELL
Open market or private sale
|
Direct |
850
-100.0%
|
$22,950
$27.6 P/Share
|
Apr 19
2021
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-57.14%
|
$250,000
$25.0 P/Share
|
Apr 19
2021
|
Ryan Martins Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+36.36%
|
$30,000
$3.11 P/Share
|
Apr 16
2021
|
Ram Waisbourd Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$168,000
$24.22 P/Share
|
Apr 16
2021
|
Ram Waisbourd Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$7,000
$1.93 P/Share
|
Apr 01
2021
|
Ra Capital Management, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
628,277
+28.83%
|
$14,450,371
$23.68 P/Share
|